abstract |
The present invention pertains to compounds of general formula (I) wherein R1, R2, R3, and R4 denote hydrogen or hydroxy with the proviso that R1, R2, R3, and R4 cannot simultaneously represent hydrogen. These compounds bind to the Serotonine and dopamine receptors and are useful in the treatment of CNS disorders. |